Rheva ABActive

559123-7663Limited company (AB)Registered 2017OXIE

Key figures

129 071 kr−59,8%
Revenue 2025
−26,9%
Average annual change 2022–2025
0200 k400 k600 k2022202320242025

Key figures

2025
Balance structure
Current assetsFixed assetsLiabilitiesEquity
0200 k400 k600 k2022202320242025
Summary of annual reports2022–2025
2022202320242025
Balance sheet — assets
Total current assets398 287421 962174 330301 259
Total non-current assets15 00015 00015 00070 000
Total assets413 287436 962189 330371 259
Balance sheet — liabilities and equity
Current liabilities77 13824 79983 14765 779
Non-current liabilities———429 714
Total liabilities77 13889 79983 147495 493
Share capital50 00050 00050 00050 000
Retained earnings of previous periods————
Profit for the year (equity)107 448161 014−140 980−275 416
Total equity336 149347 163106 183−124 234
Income statement
Sales revenue330 000584 000321 000129 071
Operating profit107 424265 526−205 866−238 778
EBITDA143 424265 526——
Profit before income tax107 448201 260−140 980−275 416
Profit for the reporting year107 448161 014−140 980−275 416
Labour costs2 0722 4750—
Depreciation of non-current assets36 0000——
Other indicators
Employees0000
Proposed dividend————

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Summary: Rheva AB

Overview

Rheva AB (org. no. 559123-7663) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Oxie. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).

Economy

Net sales in financial year 2025 were 129 071 kr, down 59,8 % on the previous year (321 000 kr). From 2022 to 2025, net sales declined by an average of 26,9 % per year. This is the lowest net sales among the reported years (2022–2025). Financial year 2025 ended with a loss of 275 416 kr. The company was profitable in 2 of the 4 reported financial years. According to the annual report, the company had no employees in financial year 2025.

Points to note

Equity was negative at the end of financial year 2025 (−124 234 kr). Equity is below half of the share capital (50 000 kr); under the Swedish Companies Act the board may then need to prepare a balance sheet for liquidation purposes (kontrollbalansräkning).

Sources and freshness

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 4 people. Data as of 2026-10-12. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.